Keeps Biopharma Inc. (KOSDAQ:256940)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,000
-150 (-1.48%)
At close: Dec 5, 2025

Keeps Biopharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
200,78197,681119,991127,866235,610309,093
Upgrade
Market Cap Growth
82.44%-18.59%-6.16%-45.73%-23.77%428.37%
Upgrade
Enterprise Value
246,774122,355160,512124,281215,414294,582
Upgrade
Last Close Price
10000.005210.006400.006820.0013100.0020150.00
Upgrade
PE Ratio
-87.7330.53---
Upgrade
Forward PE
-3.213.213.213.213.21
Upgrade
PS Ratio
1.270.771.308.7555.3020.31
Upgrade
PB Ratio
2.231.552.052.453.876.07
Upgrade
P/TBV Ratio
7.058.764.502.453.926.28
Upgrade
P/OCF Ratio
-20.31----
Upgrade
EV/Sales Ratio
1.560.961.748.5050.5619.36
Upgrade
EV/EBITDA Ratio
-13.8935.65--1355.37
Upgrade
EV/EBIT Ratio
-19.6552.45---
Upgrade
Debt / Equity Ratio
0.790.880.830.550.450.41
Upgrade
Debt / EBITDA Ratio
29.156.3310.73--95.42
Upgrade
Asset Turnover
0.880.900.910.160.050.26
Upgrade
Inventory Turnover
7.198.5722.907.054.016.10
Upgrade
Quick Ratio
0.800.470.400.991.591.67
Upgrade
Current Ratio
1.550.830.841.352.102.29
Upgrade
Return on Equity (ROE)
0.30%2.65%6.25%-21.28%-29.03%-6.27%
Upgrade
Return on Assets (ROA)
-0.26%2.76%1.89%-6.23%-9.03%-0.42%
Upgrade
Return on Capital (ROIC)
-0.35%3.45%2.04%-6.57%-9.61%-0.45%
Upgrade
Return on Capital Employed (ROCE)
-0.50%7.80%5.00%-16.70%-19.50%-0.70%
Upgrade
Earnings Yield
-0.01%1.14%3.28%-8.90%-6.50%-0.78%
Upgrade
FCF Yield
-7.77%-1.83%-0.87%-0.75%-3.60%-0.90%
Upgrade
Buyback Yield / Dilution
-1.54%-0.38%-0.40%-8.22%-18.22%-14.07%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.